FDG PET/CT in differentiated thyroid cancer patients with low thyroglobulin levels

Objective To evaluate the usefulness of [18F]fluorodeoxyglucose (FDG) positron emissive tomography (PET)/CT in patients with low detectable thyroglobulin levels suspicious for persistent or recurrent differentiated thyroid cancer (DTC). Methods A retrospective case series study evaluating FDG PET/CT...

Full description

Saved in:
Bibliographic Details
Published in:European journal of endocrinology 2022-07, Vol.187 (1), p.101-110
Main Authors: Lebbink, Chantal A, de Vries, Lisa H, Borel Rinkes, Inne H M, Braat, Arthur J A T, van Leeuwaarde, Rachel S, Lodewijk, Lutske, van Treijen, Mark J C, Vriens, Menno R, Valk, Gerlof D, van Santen, Hanneke M, de Keizer, Bart
Format: Article
Language:English
Subjects:
Adenocarcinoma
Fluorodeoxyglucose F18
Humans
Iodine Radioisotopes
Lymph nodes
Metastases
Metastasis
Neoplasm Recurrence, Local - pathology
Original
Patients
Positron emission tomography
Positron Emission Tomography Computed Tomography
Retrospective Studies
Thyroglobulin
Thyroid cancer
Thyroid Neoplasms - diagnostic imaging
Thyroid Neoplasms - pathology
Thyroid Neoplasms - surgery
Thyroidectomy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective To evaluate the usefulness of [18F]fluorodeoxyglucose (FDG) positron emissive tomography (PET)/CT in patients with low detectable thyroglobulin levels suspicious for persistent or recurrent differentiated thyroid cancer (DTC). Methods A retrospective case series study evaluating FDG PET/CT in patients with detectable thyroglobulin (Tg) levels (≥0.20 and
ISSN:0804-4643
1479-683X
DOI:10.1530/EJE-22-0072